This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2005;293:2332.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Institute of Medicine (IOM) has called for a national network of cord blood stem cell banks that could ultimately provide transplantable hematopoietic progenitor cells for most patients who would benefit from such transplants.

In a report released April 14 that had been requested by the US Congress last year, the IOM suggested that the Department of Health and Human Services establish a National Cord Blood Policy Board to create rules for donation, collection, and use of cord blood, which is now routinely discarded. Cord blood is a good source of hematopoietic progenitor cells that give rise to a variety of blood cells, which have been transplanted in patients with such hematologic diseases as leukemia, lymphoma, or sickle cell anemia. It is now considered superior to bone marrow as a source of transplantable stem cells for allogeneic transplants because its progenitor cells have a lower rejection rate than . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?